Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Hegno Pharmaceutical Holding is a high-tech pharmaceutical company specializing in the research, development, production, and marketing of active pharmaceutical ingredients (APIs) and nutritional ingredients. Headquartered in Shanghai, China, the company operates multiple manufacturing sites in Inner Mongolia and the Yangtze River Delta, leveraging over 60 years of collective experience in API manufacturing. Hegno is a major global supplier of vitamins, including Biotin (Vitamin H), Riboflavin (Vitamin B2), and Pyridoxine (Vitamin B6), as well as various antibiotics and antifungal agents. As a key member of the Acebright Pharmaceuticals Group, the company provides integrated CDMO services and regulatory support to the global pharmaceutical industry, maintaining a significant market share in the vitamin and API sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Hegno Pharmaceutical Holding.